You are here: Home » Companies » News
Business Standard

Lincoln Pharma gets patent for anti-malarial drug

The drug is painless and gives faster relief to the patients, Lincoln Pharma said

Press Trust of India  |  New Delhi 

Pharma

has been awarded a patent for anti-malarial drug in India, the company said on Tuesday.

The patent has been awarded by the Indian for an Arteether injection to treat malaria, according to a filing.

The drug is painless and gives faster relief to the patients, said.

The company expects significant rise in the from to Africa after the introduction of this injection in the African market.

"With the introduction of this injection in African countries, where total anti-malarial market is Rs 586 crore, the company expects to increase from Africa by Rs 35-40 crore," it added.

At present, the company's anti-malarial drug to Africa amounts to Rs 50 crore.

of the company were trading at Rs 221.15 apiece on BSE, up 2.65 per cent from the previous close.

First Published: Tue, December 19 2017. 13:34 IST
RECOMMENDED FOR YOU